Risiko telogen effluvium pada pasien pasca-COVID-19
DOI:
https://doi.org/10.25170/djm.v22i3.4324Keywords:
COVID-19, pull-test, hair loss, telogen effluviumAbstract
Pendahuluan: Novel coronavirus disease (COVID-19) merupakan penyakit infeksi yang disebabkan oleh severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Salah satu contoh gejala pasca-COVID adalah kerontokan rambut (telogen effluvium). Oleh karena itu COVID-19 banyak dikaitkan dengan kejadian telogen effluvium. Tujuan dari penelitian ini adalah untuk mencari hubungan antara kejadian pasca-infeksi COVID-19 dengan telogen effluvium pada pasien Klinik Sukma.
Metode: Metode yang digunakan pada penelitian ini adalah chi-square dengan cara membagikan kuesioner dan melakukan pull test. Sampel diambil secara consecutive sampling, kemudian dianalisis menggunakan Pearson’s chi-square dengan Yates’ correction.
Hasil: Jumlah pasien pasca-COVID-19 dengan kejadian rambut rontok sebesar 35 (55,6%). Tidak dapat hubungan yang bermakna secara statistik antara infeksi COVID-19 dengan kejadian rambut rontok (p=0,471). Namun demikian, orang yang terinfeksi COVID-19 berisiko 1,2 kali lebih besar untuk mengalami kerontokan rambut.
Simpulan: Dapat disimpulkan bahwa pasien pasca-COVID-19 berisiko terkena telogen effluvium dan dibutuhkan analisis multivariat pada variabel faktor lainnya.
Downloads
References
Menaldi SL, Bramono K, Indriatmi W. Buku ilmu penyakit kulit dan kelamin. 7th ed. Jakarta: Badan Penerbit FKUI; 2019. P. 363-5.
Liyanage D, Sinclair R. Telogen effluvium. Cosmetics. 2016; 3(2):13.
Wolff H, Fischer TW, Blume-Peytavi U. The diagnosis and treatment of hair and scalp diseases. Dtsch Arztebl Int. 2016 May 27;113(21):377-86.
Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus Disease 2019-COVID-19. Clin Microbiol Rev. 2020 Jun 24;33(4):e00028-20.
Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020 Sep;508:254-66.
World Health Organization (WHO) Emergency Committee. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) [Internet]. 2020 [cited 2023 Apr 4]. Available from: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)
The Lancet. Facing up to long COVID. The Lancet. 2020 Dec;396(10266):1861.
Aksoy H, Yıldırım UM, Ergen P, Gürel MS. COVID-19 induced telogen effluvium. Dermatol Ther. 2021 Nov;34(6):e15175.
McDonald KA, Shelley AJ, Colantonio S, Beecker J. Hair pull test: Evidence-based update and revision of guidelines. J Am Acad Dermatol. 2017 Mar;76(3):472-7.
Wolff K, Johnson RA, Saavedra AP, Roh EK. Fitzpatrick’s color atlas and synopsis of clinical dermatology. 8th ed. USA: McGraw-Hill Education; 2017. p. 794-6.
Wei N, Elbogen E, Dan J, Chessky A, Rivera-Oyola R, Lebwohl M, et al. Telogen effluvium in patients recovering from COVID-19. SKIN The Journal of Cutaneous Medicine, 5(5):533-7.
Inamadar AC. Covid Induced Telogen Effluvium (CITE): An insigh. Indian Dermatol Online J. 2022 Jun 24;13(4):445-8.
Aksoy H, Yıldırım UM, Ergen P, Gürel MS. COVID-19 induced telogen effluvium. Dermatol Ther. 2021 Nov 1;34(6).
Monari P, Gualdi G, Bettoni G, Costa R, Ragni G, Zani F, et al. Post-SARS-CoV-2 acute telogen effluvium: An expected complication. J Clin Med. 2022 Feb 24;11(5):1234.
Seyfi S, Alijanpour R, Aryanian Z, Ezoji K, Mahmoudi M. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity. J Med Life. 2022 May 1;15(5):631-4.
Sharquie KE, Jabbar RI. COVID-19 infection is a major cause of acute telogen effluvium. Irish Journal of Medical Science (1971 -). 2022 Aug 31;191(4):1677-81.
Hernández Arroyo J, Izquierdo-Condoy JS, Ortiz-Prado E. A case series and literature review of telogen effluvium and alopecia universalis after the administration of a heterologous COVID-19 vaccine scheme. Vaccines (Basel). 2023 Feb 15;11(2):444.
Miyazato Y, Morioka S, Tsuzuki S, Akashi M, Osanai Y, Tanaka K, et al. Prolonged and late-onset symptoms of coronavirus disease 2019. Open Forum Infect Dis. 2020 Oct 21;7(11):ofaa507.
Jimeno-Almazán A, Pallarés JG, Buendía-Romero Á, Martínez-Cava A, Franco-López F, Sánchez-Alcaraz Martínez BJ, et al. Post-COVID-19 syndrome and the potential benefits of exercise. Int J Environ Res Public Health. 2021 May 17;18(10):5329.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Damianus Journal of Medicine
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
